ADMA Biologics, Inc. (ADMA)
9.545
-0.30
(-3.00%)
USD |
NASDAQ |
Aug 24, 16:00
9.545
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics Price to Book Value : 5.269 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 5.432 |
| August 20, 2026 | 5.388 |
| August 19, 2026 | 5.548 |
| August 18, 2026 | 5.267 |
| August 17, 2026 | 5.156 |
| August 14, 2026 | 5.228 |
| August 13, 2026 | 5.195 |
| August 12, 2026 | 5.399 |
| August 11, 2026 | 5.468 |
| August 10, 2026 | 5.383 |
| August 07, 2026 | 5.465 |
| August 06, 2026 | 5.554 |
| August 05, 2026 | 5.112 |
| August 04, 2026 | 4.919 |
| August 03, 2026 | 4.825 |
| July 31, 2026 | 4.670 |
| July 30, 2026 | 4.786 |
| July 29, 2026 | 4.808 |
| July 28, 2026 | 4.853 |
| July 27, 2026 | 4.682 |
| July 24, 2026 | 4.566 |
| July 23, 2026 | 4.621 |
| July 22, 2026 | 4.626 |
| July 21, 2026 | 4.742 |
| July 20, 2026 | 4.830 |
| Date | Value |
|---|---|
| July 17, 2026 | 4.808 |
| July 16, 2026 | 4.864 |
| July 15, 2026 | 4.792 |
| July 14, 2026 | 4.897 |
| July 13, 2026 | 4.952 |
| July 10, 2026 | 5.013 |
| July 09, 2026 | 5.118 |
| July 08, 2026 | 5.057 |
| July 07, 2026 | 5.084 |
| July 06, 2026 | 5.057 |
| July 02, 2026 | 4.941 |
| July 01, 2026 | 4.753 |
| June 30, 2026 | 4.621 |
| June 29, 2026 | 4.981 |
| June 26, 2026 | 5.207 |
| June 25, 2026 | 5.189 |
| June 24, 2026 | 5.178 |
| June 23, 2026 | 5.172 |
| June 22, 2026 | 5.100 |
| June 18, 2026 | 4.945 |
| June 17, 2026 | 5.011 |
| June 16, 2026 | 5.106 |
| June 15, 2026 | 5.058 |
| June 12, 2026 | 4.886 |
| June 11, 2026 | 4.951 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Erasca, Inc. | 15.21 |
| Krystal Biotech, Inc. | 7.442 |
| Vericel Corp. | 5.857 |
| Emergent BioSolutions, Inc. | 0.7768 |
| Exelixis, Inc. | 7.366 |
Price to Book Value Related Metrics
| PE Ratio | 13.55 |
| PS Ratio | 4.466 |
| Price to Free Cash Flow | 19.69 |
| Price | 9.545 |
| Earnings Yield | 7.38% |
| Market Cap | 2.151B |
| Operating PE Ratio | 10.57 |
| Normalized PE Ratio | 13.43 |